Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

736.75 -19.15 (-2.53%)
Streaming Delayed Price Updated: 12:04 PM EDT, May 3, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9
...
76 77 Next >
Comparative Study: Eli Lilly and Co And Industry Competitors In Pharmaceuticals Industry
Via Benzinga
Wage Growth Slows – Stock Market Celebrates, Five Real Reasons Apple Is Running Up
To gain an edge, this is what you need to know today. 
Via Benzinga
1 Wall Street Analyst Thinks Eli Lilly Stock Is Going to $892. Is It a Buy?
The company seems to be going from strength to strength lately. 
Via The Motley Fool
Weigh Loss Competition Heats Up In Britain, Online Pharmacies Slash Prices for Wegovy and Mounjaro
Reduced prices on Wegovy and Mounjaro at British pharmacies amid growing competition. Simple Online Pharmacy slashes Mounjaro starter doses to £149 from £179, catering to high demand. 
Via Benzinga
Unpacking the Latest Options Trading Trends in Eli Lilly and Co
Via Benzinga
Here's Why Eli Lilly Stock Remains a Screaming Buy
The biggest healthcare company in the world could grow much larger over the next decade. 
Via The Motley Fool
What 23 Analyst Ratings Have To Say About Eli Lilly and Co
Via Benzinga
Why Eli Lilly Stock Is Jumping Today
Investors are cheering the big-pharma company's improved outlook. 
Via The Motley Fool
3 Stocks Gunning for Trillion-Dollar Status: The Players to Own Now
These three stocks closing in on trillion-dollar valuations are ready to stand shoulder-to-shoulder with other industry giants. 
Via InvestorPlace
Demand Soars For Novo Nordisk's Weight-Loss Drug Wegovy Despite Supply Constraints And Eli Lilly Competition
The Danish pharmaceutical company is now shipping more introductory doses of Wegovy to the U.S., as it grapples with supply constraints and competition from Eli Lilly. 
Via Benzinga
Q1 Earnings Seasons Picks & Pans: The 4 Biggest Stock Winners (and 3 Losers)
Investors should take note of this earnings season winners and losers to see how stocks they own are doing now Q1 results have been released. 
Via InvestorPlace
Eli Lilly 'On Its Way' To $1 Trillion Market Cap, Analysts Say: It's A 'Have' In A Sea Of 'Have Nots'
Eli Lilly's first-quarter report shows a revenue surge of 26%, beating EPS expectations. Analysts maintain a bullish outlook. 
Via Benzinga
ETFs To Buy As Eli Lilly Beats Q1 Earnings, Lifts Outlook
Eli Lilly and Company posted mixed first-quarter 2024 earnings, beating earnings estimates but lagging on revenues. Investors seeking to tap the opportune moment could bet on ETFs having the largest... 
Via Talk Markets
Topics ETFs
Profit from the Panic: 3 Stocks to Pounce on When They Become Steals
We love it when our favorite clothes go on sale, so when the market offers us a deal, these are the stocks to buy on dips. 
Via InvestorPlace
Stock Market Crash Warning: Don’t Get Caught Holding These 3 Consumer Stocks.
While some retail companies are still thriving, investors would be smart to steer clear of these consumer stocks to avoid. 
Via InvestorPlace
Stock Market Crash Alert: 3 Must-Buy Biotech Stocks When Prices Plunge
A slip in the market could give investors a rare opportunity to get some top biotech stocks to buy at a considerable discount. 
Via InvestorPlace
3 Healthcare Stocks With the Potential to Triple Your Investment by 2026
Learn how these three healthcare stocks offer sharp opportunities in pharmaceuticals, healthcare services, and biotechnology. 
Via InvestorPlace
Pfizer Embraces Direct-To-Consumer Model For Covid Antiviral, Says Comirnaty Revenues Continue To Perform Consistently With Expectations
Pfizer reports Q1 results: adjusted EPS beats estimates, driven by revenue growth. Significant declines in Comirnaty and Paxlovid revenues countered by operational gains. Company announces plans for... 
Via Benzinga
Exposures COVID-19
Nearly 50% of Billionaire Stanley Druckenmiller's Portfolio Is Invested in These 4 Stocks
The billionaire's family fund is surprisingly concentrated. 
Via The Motley Fool
How Consumer Demand Is Impacting Taiwan Semiconductor Manufacturing Co.
We also look at the "treasure hunt" economy. 
Via The Motley Fool
These 3 Companies Recently Lifted Guidance
Several companies have raised their outlooks, with shares moving higher following the announcements. For those interested in recent bullish activity, let’s take a closer look at each. 
Via Talk Markets
Americans Swap $5 Burgers For $1,000 Weight Loss Drugs — Is Soda Getting Left Behind Too?
Weight-loss drugs may be impacting fast-food sales, as Eli Lilly beats estimates and raises revenue guidance while McDonald's and Coca-Cola report underwhelming quarters. 
Via Benzinga
Goldman Scrutinizes Hits, Misses, And Growth Trajectory Concerns For Eli Lilly And Its Its Obesity and Diabetes Drugs
Eli Lilly boosts production for obesity and diabetes drugs, reports mixed Q1 results. Expectations for supply growth in 2024 outlined. Insights into payor access and reimbursement strategies... 
Via Benzinga
Eli Lilly (LLY) Q1 2024 Earnings Call Transcript
LLY earnings call for the period ending March 31, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
FOMC Meeting Samsung Over Takes Apple, AI Demand Indication Ahead From AMD, Amazon And Super Micro
To gain an edge, this is what you need to know today. 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Stocks Dive On Fears Of Hawkish Fed; Treasury Yields Rise, Bitcoin Tumbles To $60,000: What's Driving Markets Tuesday?
Investor apprehension grips Wall Street with major indices showing midday losses on Tuesday in New York trading, ahead of the Federal Reserve’s potentially hawkish pivot in Wednesday’s meeting. 
Via Benzinga
Eli Lilly Increases FY24 Outlook, Joins Brinker International, Zebra Technologies, 3M And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Why H&E Equipment Services Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
LLY Stock Earnings: Eli Lilly Beats EPS, Misses Revenue for Q1 2024
LLY stock results show that Eli Lilly beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9
...
76 77 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.